NasdaqGM - Nasdaq Real Time Price USD

Braveheart Bio, Inc. (BRVE)

18.60 +1.18 (+6.80%)

At close: November 6 at 4:00:01 PM EST

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or Entity	Most Recent Transaction	Date	Shares Owned as of Transaction Date
CHIMOVITS EREZ Director and Beneficial Owner of more than 10% of a Class of Security	Purchase	Aug 7, 2026	--
JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Aug 7, 2026	7,420,090
LUBNER DAVID CHARLES Director	Purchase	Aug 7, 2026	55,555
MURDOCH TRAVIS Chief Executive Officer	Purchase	Aug 7, 2026	8,333,640
RICKEY JAMES PAUL Chief Financial Officer	Purchase	Aug 7, 2026	703,575
VIEHBACHER CHRISTOPHER Director	Purchase	Aug 7, 2026	759,857